283 related articles for article (PubMed ID: 20531173)
21. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
[TBL] [Abstract][Full Text] [Related]
22. Dosing dilemmas in obese children.
Mulla H; Johnson TN
Arch Dis Child Educ Pract Ed; 2010 Aug; 95(4):112-7. PubMed ID: 20585055
[TBL] [Abstract][Full Text] [Related]
23. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.
Polso AK; Lassiter JL; Nagel JL
J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631
[TBL] [Abstract][Full Text] [Related]
24. Drug disposition in obesity: toward evidence-based dosing.
Knibbe CA; Brill MJ; van Rongen A; Diepstraten J; van der Graaf PH; Danhof M
Annu Rev Pharmacol Toxicol; 2015; 55():149-67. PubMed ID: 25340929
[TBL] [Abstract][Full Text] [Related]
25. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
Gabrielsson J; Green AR
J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
[TBL] [Abstract][Full Text] [Related]
26. Drug interactions in dental practice.
Gerald MC
Dent Clin North Am; 1978 Jan; 22(1):151-71. PubMed ID: 23326
[No Abstract] [Full Text] [Related]
27. Effect of morbid obesity on kinetic of desflurane: wash-in wash-out curves and recovery times.
La Colla G; La Colla L; Turi S; Poli D; Albertin A; Pasculli N; Bergonzi PC; Gonfalini M; Ruggieri F
Minerva Anestesiol; 2007 May; 73(5):275-9. PubMed ID: 17529920
[TBL] [Abstract][Full Text] [Related]
28. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
29. Pharmacology in the elderly and newer anaesthesia drugs.
Kruijt Spanjer MR; Bakker NA; Absalom AR
Best Pract Res Clin Anaesthesiol; 2011 Sep; 25(3):355-65. PubMed ID: 21925401
[TBL] [Abstract][Full Text] [Related]
30. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
Kendrick JG; Carr RR; Ensom MH
Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
[TBL] [Abstract][Full Text] [Related]
31. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
32. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.
Emery MG; Fisher JM; Chien JY; Kharasch ED; Dellinger EP; Kowdley KV; Thummel KE
Hepatology; 2003 Aug; 38(2):428-35. PubMed ID: 12883487
[TBL] [Abstract][Full Text] [Related]
33. The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjects.
Dvorchik BH; Damphousse D
J Clin Pharmacol; 2005 Jan; 45(1):48-56. PubMed ID: 15601805
[TBL] [Abstract][Full Text] [Related]
34. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
[TBL] [Abstract][Full Text] [Related]
35. Desflurane versus sevoflurane for laparoscopic gastroplasty in morbidly obese patients.
Vallejo MC; Sah N; Phelps AL; O'Donnell J; Romeo RC
J Clin Anesth; 2007 Feb; 19(1):3-8. PubMed ID: 17321919
[TBL] [Abstract][Full Text] [Related]
36. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses.
Whittem T; Pasloske KS; Heit MC; Ranasinghe MG
J Vet Pharmacol Ther; 2008 Dec; 31(6):571-9. PubMed ID: 19000281
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of doxorubicin and etoposide in a morbidly obese pediatric patient.
Ritzmo C; Söderhäll S; Karlén J; Nygren H; Eksborg S
Pediatr Hematol Oncol; 2007 Sep; 24(6):437-45. PubMed ID: 17710661
[TBL] [Abstract][Full Text] [Related]
38. Special aspects of pharmacokinetics of inhalation anesthesia.
Hendrickx JF; De Wolf A
Handb Exp Pharmacol; 2008; (182):159-86. PubMed ID: 18175091
[TBL] [Abstract][Full Text] [Related]
39. Gender differences in pharmacokinetics and pharmacodynamics.
Beierle I; Meibohm B; Derendorf H
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):529-47. PubMed ID: 10584975
[TBL] [Abstract][Full Text] [Related]
40. Leptin concentrations do not correlate with fat mass nor with metabolic risk factors in morbidly obese females.
García-Lorda P; Bulló M; Vilà R; del Mar Grasa M; Alemany M; Salas-Salvadó J
Diabetes Nutr Metab; 2001 Dec; 14(6):329-36. PubMed ID: 11853365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
